Advocate Sherman Hospital is a hospital located in Elgin, Illinois. It contains 255 beds, and is one of the most premier regional hospitals in the country, specializing in heart surgeries. It is ranked "high performing" in dealing with heart failure by U.S. News.

There are 255 beds in Advocate Sherman Hospital.

During the past decade, Advocate Sherman Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 29 clinical trials were completed, i.e. on average, 170.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advocate Sherman Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advocate Sherman Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Advocate Sherman Hospital" are "Breast Cancer" (10 trials), "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials) and "Adenocarcinoma of the Prostate" (2 trials). Many other conditions were trialed in "Advocate Sherman Hospital" in a lesser frequency.

Most popular intervention types in "Advocate Sherman Hospital" are "Drug" (47 trials), "Other" (32 trials), "Biological" (25 trials), "Procedure" (9 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (10 trials), "Bevacizumab" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Advocate Sherman Hospital" are 41 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Advocate Sherman Hospital". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Advocate Sherman Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Advocate Sherman Hospital, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".